Frequency of continuing mucosal inflammation in clinically inactive chrohn's disease

Scottish Medical Journal

Volumn 46, Issue 5, 2001, Pages 136-139

  Arnott, I D R ^a   Drummond, H E ^a   Ghosh, S ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; ELASTASE; HEMOGLOBIN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 8; MESALAZINE; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; GRANULOCYTE; HEALING; HUMAN; INCIDENCE; INTESTINE LAVAGE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PARAMETER; PROSPECTIVE STUDY; REMISSION; SERUM;

EID: 0035210621     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1177/003693300104600504     Document Type: Article

References (29)

1. Incidence of juvenile-onset Crohn's disease in Scotland
2. Tumour necrosis factor a and interleukin 1b in relapse of Crohn's disease
3. Gut lavage protein concentrations: Objective measures of disease activity in inflammatory bowel disease
4. Soluble Fc gamma receptor 111 (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: Reflection of mucosal inflammation
5. Gut lavage fluid proteins as markers of activity of inflammatory bowel disease
6. Enhanced mucosal cytokine production in inflammatory bowel disease
7. Interleukin- 1 and interleukin- 1 receptor antagonist in inflammatory bowel disease
8. Proinflammatory cytokines in inflammatory bowel disease
9. Cytokine production in patients with inflammatory bowel disease
10. Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease
11. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease
12. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease
13. Review Article: Pathobiology of neutrophil interactions with intestinal epithelia
14. Investigation of neutropils in the gut lumen by assay of granulocyte elastase in whole gut lavage fluid
15. Gut lavage IgG and interleukin 1 receptor antagonist: Interleukin 10 ratio as markers of intestinal inflammation in children with inflammatory bowel disease
16. Whole gut lavage fluid analysis: A minimally invasive method for study of mucosal immunity and inflammation
17. Clinical remission in Crohn's disease-assessment using faecal 111In granulocyte excretion
18. Development of a Crohn's disease index; National cooperative Crohn's disease study
19. Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss
20. Appraisal of gut lavage in the study of intestinal immunity
21. Haemoglobin in gut lavage as a measure of gastrointestinal blood loss
22. L-pyroglutamyl-L-propyl-L-valinep-nitroanilide, a highly specific substrate for granulocyte elastase
23. A paediatric Crohn's disease activity index (PCDAI). Is it useful?
24. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease
25. Indium 11 1-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease
26. Quantification of disease activity in Crohn's disease by computer analysis of Tc-99m hexamethyl porpylene amine oxime (HMPAO) labelled leucocye images
27. Early and delayed indium 111 leukocyte imaging in Crohn's disease
28. Can 111 -indium autologous mixed leucocyte scanning accurately assess disease extent and severity in Crohn's disease?
29. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease